Use of PKC inhibitors in diabetic complications

Details for Australian Patent Application No. 2007264002 (hide)

Owner Novartis AG

Inventors Wagner, Jurgen; Evenou, Jean-Pierre

Agent Davies Collison Cave

Pub. Number AU-B-2007264002

PCT Pub. Number WO2008/000484

Priority 0613162.7 30.06.06 GB

Filing date 28 June 2007

Wipo publication date 3 January 2008

Acceptance publication date 8 September 2011

International Classifications

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

22 January 2009 PCT application entered the National Phase

  PCT publication WO2008/000484 Priority application(s): WO2008/000484

8 September 2011 Application Accepted

  Published as AU-B-2007264002

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007264006-Biomaterial containing degradation stabilized polymer

2007264001-Phenol derivatives for the treatment of respiratory diseases